France· FR:63305905
BUSPIRONE SANDOZ 10 mg, comprimé sécable
A buspirone product containing chlorhydrate de buspirone, registered in France by SANDOZ, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Buspirone is registered in 12 of 19 countries.
Countries holding a registration under ATC N05BE01 (buspirone), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 6 of them publish a price we can compare per daily dose
Buspirone · ATC N05BE01
12 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of buspirone costs, country by country.
Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.
- France: $0.60 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Buspirone · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- FR France$0.60
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE BUSPIRONE
- Manufacturer
- SANDOZ
- Country
- France (FR)
- ATC code
- N05BE01
- ATC class
- Buspirone
- Defined daily dose
- 30 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400937665537plaquette(s) aluminium polypropylène de 20 comprimé(s)EUR 3.52
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
258 interactions on record for buspirone.
Graded by severity as the source publishes them — 22 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Buspirone · interactions on record
258 records
- 22 severe
- 118 moderate
- 118 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Buspirone in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesbusPIRone HClAdvagen Pharma Ltd
- United KingdomBuspar 10mg tabletsWaymade Healthcare Plc
- CanadaAMB-BUSPIRONEAMBICARE PHARMACEUTICALS INC.
- SwedenAnksilon 10 mg TablettOrion Corporation
- FinlandAnksilonOrion Corporation
- PolandSpamilanEGIS Polska Spółka z o.o.
- NorwayBuripal2care4 Generics ApS
- NetherlandsBuspiron HCl CF 10 mg, tablettenCentrafarm B.V.
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Czechia · Buspiron-Egis
- Germany · Busp
- Denmark · Buripal, Buspiron Actavis
- Finland · Anksilon, Buspiron Ratiopharm
- United Kingdom (Northern Ireland) · Buspirone Accord-Uk, Buspirone Hydrochloride
- Greece · Antipsichos, Bergamol
- Hungary · Spitomin
- Lithuania · Spitomin
- Latvia · Spitomin
- Netherlands · Buspiron Hcl Cf, Buspiron Hcl Mylan
- Norway · Buripal, Buspirone Orion
- Poland · Spamilan
- Portugal · Ansiten, Busansil
- Romania · Spitomin
- Sweden · Anksilon, Buripal
- Slovakia · Spitomin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c99de15b-3293-4402-99c2-7726d82b5f0c GET /v1/drugs/c99de15b-3293-4402-99c2-7726d82b5f0c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63305905",
"date_amm": "1999-01-06",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CHLORHYDRATE DE BUSPIRONE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé sécable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about buspirone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.